Pretransplant Hypoalbuminemia Is Not Associated with Worse Outcomes among Simultaneous Pancreas and Kidney Transplant Recipients

Background: Hypoalbuminemia is a well-known independent risk factor predictive of worse outcomes in surgical patients. Nonetheless, the role of pre-transplant hypoalbuminemia and its impact on post-transplant outcomes in patients undergoing simultaneous kidney-pancreas (SPK) transplantation remains unclear. Methods: We retrospectively analyzed all SPK recipients at our center from 2001-2022, who had at least 2 weeks of pancreatic graft survival. Serum albumin levels measured within 6 weeks or closer to transplant were included. Recipients were categorized based on pretransplant albumin level normal (≥ 4.0 g/dl, N = 222), mild (≥3.5 - < 4.0 g/dl, N = 190), moderate (< 3.5 g/dl, N = 120). Multivariable logistic regression and Cox proportional hazard models were used to analyze associations with the length of stay (LOS), kidney delayed graft function (DGF), re-hospitalization within 30 days after discharge, and need for return to the operating room (OR) related to transplant surgical complications, along with acute rejection and uncensored and death-censored graft failure, within the first-year post-transplant. Results: A total of 532 SPK recipients were included, 42% had normal serum albumin; 36% had mild and 23% had moderate hypoalbuminemia. The mean pre-transplant albumin level was 4.3 g/dl in normal, 3.7 g/dl in the mild, and 3.0 in the moderate group. After adjustment for multiple variables, with reference to normal pre-transplant albumin level, mild or moderate hypoalbuminemia was not associated with either increased or decreased risk for LOS, DGF, re-hospitalization or return to the OR. Also, mild, or moderate hypoalbuminemia was not associated with risk for either graft rejection or graft failure. Conclusion: Among SPK recipients, pre-transplant hypoalbuminemia is not associated with worse outcomes. Pre-transplant albumin level should not be the determining factor in offering or rejecting these life-saving organs.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.2024kvj2ewhv
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pretransplant Hypoalbuminemia Is Not Associated with Worse Outcomes among Simultaneous Pancreas and Kidney Transplant Recipients

Brad C. Astor, Didier A. Mandelbrot, Dixon B. Kaufman, Jon S. Odorico et al.
Journal of the American Society of Nephrology
Liver Disease Diagnosis and Treatment
article

Pretransplant Hypoalbuminemia Is Not Associated with Worse Outcomes among Simultaneous Pancreas and Kidney Transplant Recipients

Brad C. Astor, Didier A. Mandelbrot, Dixon B. Kaufman, Jon S. Odorico, Ekaterina Fedorova, Sandesh Parajuli, Sofia Nehring Firmino
article en

Abstract

Background: Hypoalbuminemia is a well-known independent risk factor predictive of worse outcomes in surgical patients. Nonetheless, the role of pre-transplant hypoalbuminemia and its impact on post-transplant outcomes in patients undergoing simultaneous kidney-pancreas (SPK) transplantation remains unclear. Methods: We retrospectively analyzed all SPK recipients at our center from 2001-2022, who had at least 2 weeks of pancreatic graft survival. Serum albumin levels measured within 6 weeks or closer to transplant were included. Recipients were categorized based on pretransplant albumin level normal (≥ 4.0 g/dl, N = 222), mild (≥3.5 - < 4.0 g/dl, N = 190), moderate (< 3.5 g/dl, N = 120). Multivariable logistic regression and Cox proportional hazard models were used to analyze associations with the length of stay (LOS), kidney delayed graft function (DGF), re-hospitalization within 30 days after discharge, and need for return to the operating room (OR) related to transplant surgical complications, along with acute rejection and uncensored and death-censored graft failure, within the first-year post-transplant. Results: A total of 532 SPK recipients were included, 42% had normal serum albumin; 36% had mild and 23% had moderate hypoalbuminemia. The mean pre-transplant albumin level was 4.3 g/dl in normal, 3.7 g/dl in the mild, and 3.0 in the moderate group. After adjustment for multiple variables, with reference to normal pre-transplant albumin level, mild or moderate hypoalbuminemia was not associated with either increased or decreased risk for LOS, DGF, re-hospitalization or return to the OR. Also, mild, or moderate hypoalbuminemia was not associated with risk for either graft rejection or graft failure. Conclusion: Among SPK recipients, pre-transplant hypoalbuminemia is not associated with worse outcomes. Pre-transplant albumin level should not be the determining factor in offering or rejecting these life-saving organs.

Journal of the American Society of NephrologyVol. 35(10S)
University of Wisconsin–Madison (US)
Openalex Percentile: Top 71%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.